Kornitzer Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.54M Sell
5,072
-1,614
-24% -$775K 0.05% 277
2026
Q1
$3.29M Sell
6,686
-119
-2% -$64.6K 0.07% 240
2025
Q4
$3.94M Sell
6,805
-20
-0.3% -$11.3K 0.08% 248
2025
Q3
$3.31M Hold
6,825
0.07% 268
2025
Q2
$2.77M Sell
6,825
-514
-7% -$215K 0.06% 288
2025
Q1
$3.65M Buy
7,339
+312
+4% +$169K 0.08% 254
2024
Q4
$3.66M Sell
7,027
-182
-3% -$100K 0.07% 267
2024
Q3
$4.46M Buy
7,209
+140
+2% +$82.9K 0.08% 250
2024
Q2
$3.91M Buy
7,069
+791
+13% +$453K 0.07% 261
2024
Q1
$3.65M Buy
6,278
+225
+4% +$126K 0.07% 276
2023
Q4
$3.21M Sell
6,053
-241
-4% -$117K 0.06% 283
2023
Q3
$3.19M Sell
6,294
-250
-4% -$133K 0.07% 273
2023
Q2
$3.41M Sell
6,544
-792
-11% -$427K 0.07% 284
2023
Q1
$4.23M Buy
7,336
+400
+6% +$225K 0.08% 260
2022
Q4
$3.82M Hold
6,936
0.08% 273
2022
Q3
$3.52M Sell
6,936
-8
-0.1% -$4.48K 0.08% 268
2022
Q2
$3.77M Sell
6,944
-742
-10% -$408K 0.08% 273
2022
Q1
$4.54M Sell
7,686
-500
-6% -$287K 0.07% 266
2021
Q4
$5.46M Sell
8,186
-575
-7% -$359K 0.08% 264
2021
Q3
$5M Sell
8,761
-1,100
-11% -$604K 0.08% 280
2021
Q2
$4.97M Buy
9,861
+2,900
+42% +$1.37M 0.07% 276
2021
Q1
$3.18M Buy
6,961
+40
+0.6% +$19.1K 0.05% 300
2020
Q4
$3.22M Buy
6,921
+20
+0.3% +$9.38K 0.05% 298
2020
Q3
$3.05M Sell
6,901
-169
-2% -$69.8K 0.06% 280
2020
Q2
$2.56M Sell
7,070
-109
-2% -$36.5K 0.05% 300
2020
Q1
$2.04M Buy
7,179
+6,337
+753% +$2M 0.05% 308
2019
Q4
$274K Hold
842
﹤0.01% 493
2019
Q3
$245K Hold
842
﹤0.01% 481
2019
Q2
$247K Hold
842
﹤0.01% 486
2019
Q1
$230K Buy
+842
New +$210K ﹤0.01% 474

Other funds holding TMO

Kornitzer Capital Management's TMO Position: Q2 2026 in Review

Kornitzer Capital Management reduced its Thermo Fisher Scientific (TMO) stake by 24% in Q2 2026, selling an estimated $775K and leaving 5,072 shares worth $2.54M. The position accounts for 0.05% of the portfolio, ranked #277.

Kornitzer Capital Management first reported a position in TMO in Q1 2019 and has held it in 30 quarters since. The position peaked at $5.46M in Q4 2021. 1,159 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Kornitzer Capital Management held 5,072 shares of Thermo Fisher Scientific worth $2.54M as of Q2 2026.
  • Kornitzer Capital Management sold 1,614 Thermo Fisher Scientific shares in Q2 2026, an estimated $775K.
  • Thermo Fisher Scientific made up 0.05% of Kornitzer Capital Management's portfolio in Q2 2026, its #277 holding.
  • Kornitzer Capital Management first reported a position in Thermo Fisher Scientific in Q1 2019 and has held it in 30 quarters since.
  • Kornitzer Capital Management's Thermo Fisher Scientific position peaked at $5.46M in Q4 2021.
  • 1,159 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Kornitzer Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.